Detalhe da pesquisa
1.
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.
Cell
; 174(6): 1586-1598.e12, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30100188
2.
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer.
Cancer
; 130(5): 683-691, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905752
3.
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics.
Genet Med
; 26(2): 101032, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006283
4.
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer.
Tumour Biol
; 46(s1): S327-S340, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37270827
5.
RNF12 is an X-Encoded dose-dependent activator of X chromosome inactivation.
Cell
; 139(5): 999-1011, 2009 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19945382
6.
Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer.
Acta Chir Belg
; : 1-9, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38404182
7.
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study.
Lancet Oncol
; 24(11): 1219-1228, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844598
8.
A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF?
J Neurooncol
; 162(1): 1-13, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820955
9.
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice.
J Pathol
; 258(2): 179-188, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35792649
10.
X inactivation counting and choice is a stochastic process: evidence for involvement of an X-linked activator.
Cell
; 132(3): 410-21, 2008 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-18267073
11.
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol
; 35(12): 1888-1899, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115922
12.
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer.
Oncologist
; 26(4): 290-e545, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296125
13.
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
Oncologist
; 26(8): e1347-e1358, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33111480
14.
An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation Detection.
Clin Chem
; 67(7): 959-967, 2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33842952
15.
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
Br J Cancer
; 122(8): 1166-1174, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147669
16.
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort.
Mod Pathol
; 33(5): 792-801, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740722
17.
Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment.
Br J Cancer
; 119(5): 558-564, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061586
18.
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol
; 35(12): 2033, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253399
19.
Buccal swab as a reliable predictor for X inactivation ratio in inaccessible tissues.
J Med Genet
; 52(11): 784-90, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26220467
20.
A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics.
Clin Cancer Res
; 30(4): 814-823, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38088895